Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-02-15

Clinical Trial Update: Return on Investment on Lap Gastric Bypass Regarding Quality of Life

View source ↗

Summary

A clinical trial evaluating laparoscopic gastric bypass and its effect on quality of life for obesity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lund University | Conditions: Obesity | Status: WITHDRAWN